COVID-19 trials registries data warehouse

https://clinicaltrials.gov/show/NCT04308317

Henan Provincial People's Hospital

Not reported

2020-03-16

Recruiting

RCT

Randomized

Parallel

Open label

single-center

Treatment

inclusion criteria: - patients with mild and severe cases who have been diagnosed with new coronavirus pneumonia according to the "pneumonitis diagnosis and treatment - - plan for new coronavirus infection" - age 18 to 75 years; - sign the informed consent voluntarily.

- with active tuberculosis, idiopathic pulmonary fibrosis, bronchial asthma, bronchiectasis, pulmonary embolism, patients with chronic respiratory failure or other severe respiratory disease; - according to the "pneumonia diagnosis and treatment program for new coronavirus infection" (trial version 6), critically ill patients - with severe patients with disease of heart head blood-vessel, malignant arrhythmia, unstable angina, acute myocardial infarction and death, cardiac function level 3 and above, stroke, cerebral hemorrhage, etc.); - with severe liver and kidney diseases (severe liver disease refers to cirrhosis, portal hypertension and varices bleeding, severe kidney disease including dialysis, kidney transplantation); - pregnant and lactating women; - severe cognitive and mental disorders; - clinical investigators who were participating in other interventions within 1 month prior to inclusion

2

Henan Provincial People's Hospital

18

75

China

No restriction on type of patients

0: No restriction on type of patients

60

Survival rate

None

Phase 4

[{"arm_notes": "", "treatment_id": 1281, "treatment_name": "Tetrandrine", "treatment_type": "Anti-inflammatories", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]